Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial-Reference-Cited by-同舟云学术

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

Published:2006-03 Issue:9513 Volume:367 Page:825-831
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Palumbo Antonio,Bringhen Sara,Caravita Tommaso,Merla Emanuela,Capparella Vincenzo,Callea Vincenzo,Cangialosi Clotilde,Grasso Mariella,Rossini Fausto,Galli Monica,Catalano Lucio,Zamagni Elena,Petrucci Maria Teresa,De Stefano Valerio,Ceccarelli Manuela,Ambrosini Maria Teresa,Avonto Ilaria,Falco Patrizia,Ciccone Giovannino,Liberati Anna Marina,Musto Pellegrino,Boccadoro Mario

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No 5 version 2.0;Ferlay,2004

2. A prospective, randomised trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;N Engl J Med,1996

3. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

4. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomised trial;Palumbo;Blood,2004

5. Combination chemotherapy versus melphalan and prednisone as treatment of multiple myeloma: an overview of 6,633 patients from 27 randomised trials;J Clin Oncol,1998

Cited by 711 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MM Therapy in Resource-Constrained Including Maintenance;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines;Annals of Hematology;2024-04-17

3. Tumor integrin targeted theranostic iron oxide nanoparticles for delivery of caffeic acid phenethyl ester: preparation, characterization, and anti-myeloma activities;Frontiers in Pharmacology;2024-03-06

4. Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group;Thrombosis Research;2024-01

5. Cardiotoxicity;Side Effects of Cancer Therapy;2023-12-11